Glycosylated Hemoglobin and C-Peptide Market Set to Reach US$ 9.94 Billion by 2034
The glycosylated hemoglobin (HbA1c) and C-peptide market is gaining significant momentum as the global burden of diabetes continues to rise. These diagnostic biomarkers play a crucial role in monitoring long-term glucose control and assessing pancreatic beta-cell function. Increasing awareness about early diabetes diagnosis, coupled with technological advancements in diagnostic tools, is...
0 Комментарии 0 Поделились 310 Просмотры 0 предпросмотр
Спонсоры
Спонсоры
Спонсоры